Arcus Biosciences, Inc.RCUSNYSE
Loading
ROE: Returns DecliningContracting
Percentile Rank22
Studio
Year-over-Year Change

Return on equity

Latest
-55.94%
↓ 53% vs avg
Percentile
P22
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
-36.49%
Historical baseline
PeriodValueYoY Change
2025-55.94%+4.1%
2024-58.35%+12.2%
2023-66.45%-63.5%
2022-40.64%-745.2%
20216.30%+125.7%
2020-24.49%+52.6%
2019-51.70%-144.9%
2018-21.11%+38.8%
2017-34.50%-90.9%
2016-18.07%-